VitalConnect has launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring. The wearable biosensor looks for 21 different cardiac ...

The use of 24-48 hour Holter monitoring is recommended to detect atrial fibrillation and NSVT in patients with HCM. 5 Extended ECG monitoring has previously been shown to improve detection of atrial ...

Continuous cardiac monitoring, provided by devices like Holter monitors, is crucial for early detection, management, and prevention of these conditions. These devices allow healthcare providers to ...

Remote biometric monitoring technology company Biotricity recently announced securing National Institutes of Health funding from the National Heart, Blood and Lung Institute with plans to launch a ...

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...

Clinically important arrhythmias, especially nonsustained ventricular tachycardia (NSVT), may be more prevalent in patients with hypertrophic cardiomyopathy (HCM) than widely believed, suggests a ...

Researchers have discovered that a small adhesive wireless device worn on the chest for up to two weeks does a better job detecting abnormal and potentially dangerous heart rhythms than the Holter ...

SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced ...

You probably know someone with a heart condition, someone who had a heart attack or even heart surgery. I know I do. According to the Centers for Disease Control, heart disease is the leading cause of ...

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...